A Growing Problem: Sizing up the Burden of Non-melanoma Skin Cancer

Canadian Cancer Society. Canadian cancer statistics 2014. http://www.cancer.ca/∼/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2014-EN.pdf. Accessed March 7, 2015.

Wheless L , Black J , Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2010; 19(7): 1686–1695.

Krueger H , Williams D. Burden of malignancy after a primary skin cancer: recurrence, multiple skin cancers and second primary cancers. Can J Public Health. 2010; 101(4): I23–I27.

Leiter U , Eigentler T , Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014; 810: 120–140.

Kreuger H , Williams D , Chomiak M. Economic Burden of Skin Cancer in Canada: Current and Projected. Toronto, Canada: Canadian Partnership Against Cancer; 2010.

Guy GP Jr , Machlin SR , Ekwueme DU. Prevalence and costs of skin cancer treatment in the US, 2002-2006 and 2007-2011. Am J Prev Med. 2015; 48(2): 183–187.

Madan V , Lear JT , Szeimies RM. Non-melanoma skin cancer. Lancet. 2010; 375(9715): 673–685.

Tsatsou F , Trakatelli M , Patsatsi A. Extrinsic aging: UV-mediated skin carcinogenesis. Dermatoendocrinol. 2012; 4(3): 285–297.

Foley P. Current landscape for treatment of advanced basal cell carcinoma. Australas J Dermatol. 2015; 56 (suppl 1): 1–7.

Camp WL , Turnham JW , Athar M. New agents for prevention of ultraviolet-induced nonmelanoma skin cancer. Semin Cutan Med Surg. 2011; 30(1): 6–13.

Singh M , Suman S , Shukla Y. New enlightenment of skin cancer chemoprevention through phytochemicals: in vitro and in vivo studies and the underlying mechanisms. Biomed Res Int. 2014; 2014. Article ID 243452.